The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
IBD and pregnancy require careful planning. Women with IBD can have healthy pregnancies by managing their condition with ...
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...
Researchers have uncovered differences in how patients with South Asian and white ethnicity present with inflammatory bowel ...
A recent study published in the journal Medicine has found a possible connection between low vitamin D levels and increased ...
A real-world study in adolescent and young adult patients with inflammatory bowel disease (IBD) found no significant ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...
Overall, the use of 5-aminosalicylic acid (5-ASA) in combination with ustekinumab (UST) did not provide a significant benefit in patients with inflammatory bowel disease (IBD). Evidence Rating Level: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback